Add-on Intravenous Immunoglobulins in Early Myositis

Clinical trial NCT05832034 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05832034
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Inflammatory Myopathy, Idiopathic Dermatomyositis Antisynthetase Syndrome Immune-Mediated Necrotizing Myopathy Polymyositis Myositis

Start date: 2021-09-13
Primary completion: 2025-09-25
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.